Informed Consent for Intravenous Tissue Plasminogen Activator in New York State Designated Stroke Centers

Our objective was to assess informed consent procedures for intravenous tissue plasminogen activator in acute stroke among New York State (NYS) Department of Health (DOH) designated stroke centers.

Source: Journal of Stroke and Cerebrovascular Diseases - February 7, 2017 Category: Neurology Authors: Michael I. Weintraub, Anna D. Colello, Samantha A. Johnson, Fabienne McClellan, Steven P. Cole, Curtis Benesch, Steven H. Rudolph, Steven R. Levine Source Type: research